Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Obituaries I: Altus Becomes a Casualty of Development Costs, but Drug May Live On
Obituaries I: Altus Becomes a Casualty of Development Costs, but Drug May Live On
Obituaries I: Altus Becomes a Casualty of Development Costs, but Drug May Live On
Submitted by
admin
on December 21, 2009 - 10:07am
Source:
BNET Pharma
News Tags:
Altus
Trizytek
Headline:
Obituaries I: Altus Becomes a Casualty of Development Costs, but Drug May Live On
Do Not Allow Advertisers to Use My Personal information
